Home
About us
Solutions
THIN
Contact
UK

Endocrinology

Accueil
Publications
Endocrinology
Postauthorization safety study of the DPP-4...

Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomes.

Des questions sur notre activité ? Contactez-nous

Solutions

Real World Evidence Services
Patient Intelligence
Market Intelligence
Real World Data

Actualités

First papers published by French researchers managed by GERS Data
THIN is a finalist at the 2019 BOBI awards
Come and support our team at Vivatech 2019 event !
Cegedim and Sanofi are engaged in an innovative collaboration on Real World Data for healthcare improvement in Europe
Real World Data UK event in London
Cegedim Health Data to collaborate with IBM Watson Health to provide integrated access to real world data

Cegedim Health Data

About us
THIN : The Health Improvement Network
Publications

Contact

Contact
Scientific research contact
Legal information

Retrouvez Cegedim Health Data sur les réseaux sociaux

Copyright © 2022 Cegedim Health Data - Tous droits réservés - Conditions générales du site - Société du groupe Cegedim